Figure
Trajectory of laboratory values for the study patient in relation to noted clinical events
The vertical red marks and arrows denote the initiation of rADAMTS13 treatment. Blue lines and shaded areas represent corresponding means and 95% confidence intervals for 102 consecutive patients with iTTP from an established registry.
Figure reproduced from Bendapudi et al., with permission.
